Empowered Patient Podcast

Rakshith Yashvanth , Senior Product Manager, Advanced Analytics & AI at ZeOmega, emphasizes that effective AI implementation in clinical settings requires comprehensive data across clinical, social, utilization, and behavioral elements, not cherry-picked variables. Real-world data indicates that traditional social determinants of health often miss critical behavioral patterns and healthcare engage...

Dr. Seth Lederman , CEO and Co-Founder of Tonix,  describes the company's focus on chronic, debilitating, and underserved medical conditions that have been overlooked.  Fibromyalgia, a common chronic pain condition, is a prime focus, and Seth explains how recognition of this neurological condition rooted in the central nervous system has evolved. Additional research is being conducted on a Lyme di...

Dr. Seth Lederman , CEO and Co-Founder of Tonix,  describes the company's focus on chronic, debilitating, and underserved medical conditions that have been overlooked.  Fibromyalgia, a common chronic pain condition, is a prime focus, and Seth explains how recognition of this neurological condition rooted in the central nervous system has evolved. Additional research is being conducted on a Lyme di...

Dr. Mike Han , Chief Medical Officer at Ambience Healthcare, describes their AI-powered platform that, with consent, transcribes physician-patient conversations and then uses AI to create comprehensive documentation, including suggested diagnoses and coding recommendations.  By automating documentation and integrating into existing electronic health record systems, the platform enables clinicians...

Dr. Mike Han , Chief Medical Officer at Ambience Healthcare, describes their AI-powered platform that, with consent, transcribes physician-patient conversations and then uses AI to create comprehensive documentation, including suggested diagnoses and coding recommendations.  By automating documentation and integrating into existing electronic health record systems, the platform enables clinicians...

Dr. Ramon Velazquez , neuroscientist and Scientific Advisor at Mind Lab Pro, discusses the relevance of cognitive endurance to healthy aging and the need to maintain cognitive engagement.  Ramon addresses the dual challenge of modern life, where chronic stress and cognitive overstimulation can impair performance, while insufficient mental challenge also leads to decline. Topics include strategies...

Dr. Ramon Velazquez , neuroscientist and Scientific Advisor at Mind Lab Pro, discusses the relevance of cognitive endurance to healthy aging and the need to maintain cognitive engagement.  Ramon addresses the dual challenge of modern life, where chronic stress and cognitive overstimulation can impair performance, while insufficient mental challenge also leads to decline. Topics include strategies...

Suzanne Cogan , President and Chief Customer Officer at WebPT, addresses critical challenges the physical therapy and rehabiliation industry face and the opportunities to use AI to automate administrative tasks and enhance their patients' experiences. Solutions include patient activity tracking, scheduling, billing, insurance claims management ,and monitoring prior authorizations and renewals. The...

Suzanne Cogan , President and Chief Customer Officer at WebPT, addresses critical challenges the physical therapy and rehabiliation industry face and the opportunities to use AI to automate administrative tasks and enhance their patients' experiences. Solutions include patient activity tracking, scheduling, billing, insurance claims management ,and monitoring prior authorizations and renewals. The...

Eileen Heffernan , CEO and Co-Founder of Celltaxis, highlights that lymphedema is the most common lymphatic disorder and is a progressive chronic condition characterized by inflammation, fat deposition, and infections.  Currently there are no disease-modifying treatments available, requiring patients to rely on compression garments and manual therapy.  Celltaxis is developing a therapy that target...

Eileen Heffernan , CEO and Co-Founder of Celltaxis, highlights that lymphedema is the most common lymphatic disorder and is a progressive chronic condition characterized by inflammation, fat deposition, and infections.  Currently there are no disease-modifying treatments available, requiring patients to rely on compression garments and manual therapy.  Celltaxis is developing a therapy that target...

Samuel Reich , Chief Executive Officer at SAB Bio, is developing a fully human antibody therapy designed to transform type 1 diabetes treatment by preserving patients' beta cells and their ability to produce insulin, rather than just managing symptoms with insulin and glucose monitoring. The drug is produced using the company's bovine platform which uses genetically modified cows to generate human...

Samuel Reich , Chief Executive Officer at SAB Bio, is developing a fully human antibody therapy designed to transform type 1 diabetes treatment by preserving patients' beta cells and their ability to produce insulin, rather than just managing symptoms with insulin and glucose monitoring. The drug is produced using the company's bovine platform which uses genetically modified cows to generate human...

Marcus Ionker , Product Line Manager and Messaging Evangelist at Retarus, which is a cloud-based transactional electronic messaging service provider offering fax, SMS, email, and logistics services to regulated industries like healthcare. By moving fax to the cloud, Retarus helps providers and payers reduce administrative costs, improve patient services, and comply with privacy regulations. The co...

Marcus Ionker , Product Line Manager and Messaging Evangelist at Retarus, which is a cloud-based transactional electronic messaging service provider offering fax, SMS, email, and logistics services to regulated industries like healthcare. By moving fax to the cloud, Retarus helps providers and payers reduce administrative costs, improve patient services, and comply with privacy regulations. The co...

Andrew Hall , CEO of Consano Bio, is developing an allogeneic approach to treat chronic sciatica by activating healing in damaged spinal nerves, emulating the natural healing properties of human platelets.  This condition currently has no approved treatments and is managed through symptomatic approaches like opioids, muscle relaxers, or surgery. Consano Bio's lead candidate represents the first po...

Andrew Hall , CEO of Consano Bio, is developing an allogeneic approach to treat chronic sciatica by activating healing in damaged spinal nerves, emulating the natural healing properties of human platelets.  This condition currently has no approved treatments and is managed through symptomatic approaches like opioids, muscle relaxers, or surgery. Consano Bio's lead candidate represents the first po...

Isobel Handler , Senior Director of Product Management at Kontakt.io addresses critical inefficiencies in clinical exam room utilization.  By capturing data about staff-patient interactions and facility usage, the Kontakt.io platform incorporates real-time location data to optimize patient access, reduce waiting time, and improve staff safety. The solution helps healthcare organizations understand...

Isobel Handler , Senior Director of Product Management at Kontakt.io addresses critical inefficiencies in clinical exam room utilization.  By capturing data about staff-patient interactions and facility usage, the Kontakt.io platform incorporates real-time location data to optimize patient access, reduce waiting time, and improve staff safety. The solution helps healthcare organizations understand...

Dr. Steffen-Sebastian Bolz , Founder of QanatPharma, emphasizes the critical role of resistance arteries, microscopic blood vessels that regulate blood flow and pressure throughout the body, in maintaining organ function. Due to their size, these resistance arteries have been overlooked but with new lab techniques, QP is discovering how their dysfunction contributes to heart failure, cognitive imp...

Dr. Steffen-Sebastian Bolz , Founder of QanatPharma, emphasizes the critical role of resistance arteries, microscopic blood vessels that regulate blood flow and pressure throughout the body, in maintaining organ function. Due to their size, these resistance arteries have been overlooked but with new lab techniques, QP is discovering how their dysfunction contributes to heart failure, cognitive imp...

Carlos Buesa , CEO of Oryzon Genomics, specializes in developing precision medicine based on epigenetics, the regulatory mechanisms that control gene expression without altering the DNA. A key target is the LSD1 enzyme which regulates cell differentiation and is a factor in acute myeloid leukemia and CNS disorders. LSD1 inhibition addresses a fundamental insight that the same dysregulated epigenet...

Carlos Buesa , CEO of Oryzon Genomics, specializes in developing precision medicine based on epigenetics, the regulatory mechanisms that control gene expression without altering the DNA. A key target is the LSD1 enzyme which regulates cell differentiation and is a factor in acute myeloid leukemia and CNS disorders. LSD1 inhibition addresses a fundamental insight that the same dysregulated epigenet...

Paul Romness , CEO, President, and Chair of OS Therapies, which is developing an immunotherapy to treat osteosarcoma, a rare bone cancer that stimulates the immune system to identify and eliminate cancer cells. The approach upregulates positive immune factors amd downregulates negative factors resulting in a dual biomarker response and better management of side effects. OS Therapies plans to expan...

Paul Romness , CEO, President, and Chair of OS Therapies, which is developing an immunotherapy to treat osteosarcoma, a rare bone cancer that stimulates the immune system to identify and eliminate cancer cells. The approach upregulates positive immune factors amd downregulates negative factors resulting in a dual biomarker response and better management of side effects. OS Therapies plans to expan...